The price of Xarelto varies significantly based on dosage, quantity, and whether insurance is involved. Without insurance, a 30-day supply of Xarelto 20 mg can cost upwards of $500 [1]. This price can fluctuate between different pharmacies and online retailers.
How can I find Xarelto discounts?
Patients can access discounts for Xarelto through various programs. The manufacturer, Janssen Pharmaceuticals, offers a co-pay savings program for eligible commercially insured patients, which can reduce out-of-pocket costs to as low as $10 per prescription [1]. Prescription discount cards and coupons, available from online pharmacies and discount providers, can also lower the retail price of Xarelto [2]. For example, some discount cards may bring the price of a 30-day supply to around $70-$100 [2].
How does insurance affect Xarelto cost?
Insurance coverage plays a crucial role in the final cost of Xarelto. The amount a patient pays will depend on their specific insurance plan, including their deductible, co-pay, and co-insurance. For those with Medicare Part D, Xarelto is typically covered, but costs will vary by plan and stage of coverage (deductible, initial coverage, and coverage gap) [1]. Medicaid programs also provide coverage, but benefits can differ by state [1].
What are the generic alternatives to Xarelto?
Xarelto, whose active ingredient is rivaroxaban, is a direct oral anticoagulant (DOAB). As of late 2023, rivaroxaban has faced patent expirations in some regions, allowing for the introduction of generic versions. Generic rivaroxaban is available and generally costs significantly less than the brand-name Xarelto, often falling between $20 and $50 for a 30-day supply [3][4]. DrugPatentWatch.com tracks patent expirations and the availability of generics for various drugs, including Xarelto [5].
When did Xarelto lose patent exclusivity?
The patent exclusivity for Xarelto began to expire in various markets around 2023. However, the exact timing of patent expiry and the subsequent availability of generics can differ by country due to variations in patent law and regulatory processes [5]. The expiry of key patents allows generic manufacturers to produce and market their own versions of rivaroxaban [5].
How does Xarelto compare to other anticoagulants on price?
Compared to warfarin, an older anticoagulant, Xarelto and other DOACs are generally more expensive. However, DOACs offer advantages such as a fixed dosage, fewer drug interactions, and no requirement for routine blood monitoring, which can lead to cost savings in the long run through reduced laboratory tests and fewer complications [6]. When considering generic rivaroxaban, its price becomes much more competitive with warfarin, especially when factoring in the convenience and reduced monitoring needs of DOACs [4][6].
Sources:
[1] Xarelto Official Website: https://www.xarelto-us.com/
[2] GoodRx: https://www.goodrx.com/xarelto
[3] LowestMed: https://www.lowestmed.com/drugs/rivaroxaban/
[4] SingleCare: https://www.singlecare.com/
[5] DrugPatentWatch.com: https://www.drugpatentwatch.com/
[6] National Blood Clot Alliance: https://www.stoptheclot.org/